Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Cited by (1,003)

Items 601–700 of 1,003

1. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma
   Jing Li, Xiaoyun Xing, Daofeng Li, Bo Zhang, David Gardner Mutch, Ian S. Hagemann, Ting Wang · 2017 · Neoplasia
2. Radiation and Immune Checkpoint Blockade: From Bench to Clinic
   Jacob Ezra Shabason, Andy J. Minn · 2017 · Seminars in Radiation Oncology
3. Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer
   Russell William Jenkins, Rohit Thummalapalli, Jacob Carter, Israel Cañadas, David Allen Barbie · 2017 · Annual Review of Medicine
4. Targeting DNA Methyltranferases in Urological Tumors
   Ângela Marques-Magalhães, Inês C. R. Graça, Rui Henrique, Cármen Jerónimo · 2018 · Frontiers in Pharmacology
5. IFNL4 -ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer
   Wei Tang, Tiffany A. Wallace, Ming Yi, Cristina Magi‐Galluzzi, Tiffany H. Dorsey, Olusegun O. Onabajo, Adeola A Obajemu, Symone V. Jordan, Christopher A. Loffredo, Robert M. Stephens et al. · 2018 · Clinical Cancer Research
6. Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis
   Anthony Colombo, Timothy Junius Triche, Giridharan Ramsingh · 2018 · Scientific Reports
7. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis
   Catharina Wenk, Anne-Kathrin Garz, Sonja Grath, Christina Huberle, Denis Witham, Marie‐Theresa Weickert, Roberto Malinverni, Julia Niggemeyer, Michele C. Kyncl, Judith S. Hecker et al. · 2018 · Blood Advances
8. Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
   CETLAM group, Marta Cabezón, Roberto Malinverni, Joan Bargay, Blanca Xicoy, Sílvia Marcé, Ana Garrido, M. Tormo, Leonor Arenillas, Rosa Coll et al. · 2021 · Clinical Epigenetics
9. Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity
   Hai Hu, Alireza Khodadadi‐Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis A. Chiriboga, Briana Zeck, Miguel López de Rodas, Catríona M. Dowling, Kristen E. Labbe et al. · 2021 · Cancer Immunology Research
10. Disulfiram Improves the Anti-PD-1 Therapy Efficacy by Regulating PD-L1 Expression via Epigenetically Reactivation of IRF7 in Triple Negative Breast Cancer
    Xin Zheng, Zijian Liu, Mi Mi, Qiuyue Wen, Gang Wu, Liling Zhang · 2021 · Frontiers in Oncology
11. Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors
    Pei Zhang, Yang Du, Hua Bai, Zhijie Wang, Jianchun Duan, Xin Wang, Jia Yi Zhong, Rui Wan, Jiachen Xu, Xiran He et al. · 2022 · BMC Medicine
12. Transposable elements and their role in aging
    Юшкова Елена Александровна, Alexey Moskalev · 2023 · Ageing Research Reviews
13. Reactivation of senescence-associated endogenous retroviruses by ATF3 drives interferon signaling in aging
    Jian Mao, Qian Zhang, Yang Zhuang, Yinyu Zhang, Linmeng Li, Juan Pan, Lu Xu, Yuxuan Ding, Miao Wang, Yu‐Sheng Cong · 2024 · Nature Aging
14. Epigenetic therapy and chemosensitization in solid malignancy
    Sean M. Ronnekleiv‐Kelly, Anup R. Sharma, Nita Ahuja · 2017 · Cancer Treatment Reviews
15. The development and validation of EpiComet‐Chip, a modified high‐throughput comet assay for the assessment of DNA methylation status
    Todd A. Townsend, Marcus C. Parrish, Bevin P. Engelward, Mugimane G. Manjanatha · 2017 · Environmental and Molecular Mutagenesis
16. Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy
    Alison Hirukawa, Salendra Singh, Jarey H. Wang, Jonathan P. Rennhack, Matthew Swiatnicki, Virginie Sanguin‐Gendreau, Dongmei Zuo, Kamilia Daldoul, Cynthia A. Lavoie, Morag Park et al. · 2019 · Cell Reports
17. DUX4-induced bidirectional HSATII satellite repeat transcripts form intranuclear double-stranded RNA foci in human cell models of FSHD
    Sean C. Shadle, Sean R. Bennett, Chao-Jen Wong, Nancy Karreman, Amy E. Campbell, Silvère M. van der Maarel, Brenda Bass, Stephen J. Tapscott · 2019 · Human Molecular Genetics
18. New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry
    Elena Maryamchik, Kathleen Gallagher, Frederic I. Preffer, Stephan Kadauke, Marcela Valderrama Maus · 2020 · Cytometry Part B Clinical Cytometry
19. Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres
    Sandra Segura‐Bayona, Marina Villamor-Payà, Camille Stephan‐Otto Attolini, Lars M. König, María Sanchiz-Calvo, Simon J. Boulton, Travis H. Stracker · 2020 · Cell Reports
20. Self RNA Sensing by RIG-I–like Receptors in Viral Infection and Sterile Inflammation
    Jorn E. Stok, M. Eloisa Vega Quiroz, Annemarthe G. van der Veen · 2020 · The Journal of Immunology
21. Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter
    Chryssoula Kordella, Eleftheria Lamprianidou, Ιoannis Kotsianidis · 2021 · Frontiers in Oncology
22. Antiviral immunity triggered by infection-induced host transposable elements
    Benjamin G. Hale · 2021 · Current Opinion in Virology
23. Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution
    Kerstin Thol, Piotr Pawlik, Nicholas McGranahan · 2022 · Genome Medicine
24. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
    H. Josh Jang, Galen H. Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue, Justin R. Kulchycki, Ryan S. Burgos, Mahvish Tafseer, R. Katherine Alpaugh et al. · 2023 · Clinical Cancer Research
25. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
    Sha Qin, Bin Xie, Qingyi Wang, Rui Yang, Jingyue Sun, Chaotao Hu, Shuang Liu, Yongguang Tao, Desheng Xiao · 2024 · MedComm
26. Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy
    Zhanbo Yang, Bizhu Chu, Yao Tu, Lulu Li, Dawei Chen, Shouhui Huang, Wenjun Huang, Weiwen Fan, Qinyuan Li, Cunlong Zhang et al. · 2024 · Pharmacological Research
27. Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation
    Sebastian Sommer, Marjan J. Cruijsen, Rainer Claus, Hartmut Bertz, Ralph Wäsch, Reinhard Marks, Robert Zeiser, Lioudmila Bogatyreva, Nicole M. A. Blijlevens, Annette M. May et al. · 2018 · Leukemia Research
28. DNA methyltransferase inhibitors upregulate CD38 protein expression and enhance daratumumab efficacy in multiple myeloma
    Priya Choudhry, Margarette C. Mariano, Huimin Geng, Thomas G Martin, Jeffrey Lee Wolf, Sandy Wai Kuan Wong, Nina D. Shah, Arun P. Wiita · 2019 · Leukemia
29. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer
    Dandan Li, Wenhao Zhao, Xinyu Zhang, Hanning Lv, Chunhong Li, Lichun Sun · 2021 · Clinical Epigenetics
30. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma
    Shao‐Chen Yang, Wuyin Wang, Junjie Zhou, Lei Wu, Meng-Jie Zhang, Qi‐Chao Yang, Wei‐Wei Deng, Zhi‐Jun Sun · 2022 · International Immunopharmacology
31. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer
    Rueyhung Roc Weng, Hsuan‐Hsuan Lu, Chien‐Ting Lin, Chia-Chi Fan, Rong-Shan Lin, Tai‐Chung Huang, Shu‐Yung Lin, Yi‐Jhen Huang, Yi‐Hsiu Juan, Yi-Chieh Wu et al. · 2021 · Nature Communications
32. H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway
    Anne Meldgaard Hansen, Ying Chun Ge, Mikkel Bruhn Schuster, Sachin Pundhir, Janus Schou Jakobsen, Adrija Kalviša, Marta Cecylia Tapia, Sandra Leigh Gordon, Francesca Ambri, Frederik Otzen Bagger et al. · 2022 · Science Advances
33. Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix
    Damian Tobias Rieke, Sebastian Ochsenreither, Konrad Friedrich Klinghammer, Tanguy Y. Seiwert, Frederick Klauschen, Ingeborg Tinhofer, Ulrich Keilholz · 2016 · Oncotarget
34. Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis
    Maxwell J. Heinrich, Caroline A. Purcell, Andrea J. P. Pruijssers, Yang Zhao, Charles F. Spurlock, Subramaniam Sriram, Kristen M. Ogden, Terence S. Dermody, Matthew B. Scholz, Philip S. Crooke et al. · 2019 · Journal of Autoimmunity
35. The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment
    Elodie Renaude, Marie Kroemer, Romain Loyon, Delphine Binda, Christophe Borg, Michaël Boyer‐Guittaut, Éric Hervouet, Paul Peixoto · 2020 · International Journal of Molecular Sciences
36. Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency
    Lena J. McLaughlin, Lora Stojanovic, Aksinija A. Kogan, Julia L. Rutherford, Eun Yong Choi, Ray-Whay Chiu Yen, Limin Xia, Ying S. Zou, Rena G. Lapidus, Stephen B. Baylin et al. · 2020 · Proceedings of the National Academy of Sciences
37. Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
    Camilla Marisa Grunewald, Corinna Haist, Carolin König, Patrick Petzsch, Arthur Bister, Elfriede Nößner, Constanze Wiek, Kathrin Scheckenbach, Karl Köhrer, Günter Niegisch et al. · 2021 · Frontiers in Immunology
38. CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
    Yu Chen, Qiaomei Cai, Chaohu Pan, Wancheng Liu, Lili Li, Junxiao Liu, Meiling Gao, Xiaorong Li, Liguo Wang, Yu Rao et al. · 2022 · Cancer Immunology Research
39. Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression?
    Di Giorgio, Eros, Xodo, Luigi E. · 2022 · Frontiers in Immunology
40. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
    Bing Cheng, Qiang Yu, Wenyu Wang · 2023 · Journal of Biomedical Science
41. Epigenetic regulation and therapeutic targets in the tumor microenvironment
    Zhuojun Xie, Zirui Zhou, Shuxian Yang, Shiwen Zhang, Bin Shao · 2023 · Molecular Biomedicine
42. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
    Xin Su, Jian Li, Xiao Xu, Youbao Ye, Cailiu Wang, Guanglong Pang, Wenxiu Liu, Ang Liu, Changchun Zhao, Xiangyong Hao · 2024 · Journal of Translational Medicine
43. CXCR4 orchestrates the TOX-programmed exhausted phenotype of CD8+ T cells via JAK2/STAT3 pathway
    Canhui Cao, Miaochun Xu, Wei Ye, Ting Peng, Shitong Lin, Xiaojie Liu, Yashi Xu, Tian Chu, Shiyi Liu, Ping Wu et al. · 2024 · Cell Genomics
44. Mutations in histone modulators are associated with prolonged survival during azacitidine therapy
    Magnus Tobiasson, Donal P. McLornan, Mohsen Karimi, Marios Dimitriou, Monika Jansson, Asmaa Ben Azenkoud, Martin Jädersten, Greger Lindberg, Hani Abdulkadir, Austin Gladston Kulasekararaj et al. · 2016 · Oncotarget
45. The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy
    Jessica Ann Chacon, Keith Schutsky, Daniel J. Powell · 2016 · Vaccines
46. Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response
    Magali Champion, Kevin Brennan, Tom Croonenborghs, Andrew J. Gentles, Nathalie L.M.M. Pochet, Olivier Gevaert · 2017 · EBioMedicine
47. Peptides as epigenetic modulators: therapeutic implications
    Yorick Janssens, Evelien Wynendaele, Wim Vanden Berghe, Bart M. J. De Spiegeleer · 2019 · Clinical Epigenetics
48. An endogenous retroviral element exerts an antiviral innate immune function via the derived lncRNA lnc-ALVE1-AS1
    Shihao Chen, Xuming Hu, Isabelle H. Cui, Shaogen Wu, Chunfeng Dou, Yangyang Liu, Zhen Sun, Songlei Xue, Tuoyu Geng, Zongping Liu et al. · 2019 · Antiviral Research
49. Translational Theragnosis of Ovarian Cancer: where do we stand?
    Maria Grazia Perrone, Oreste Luisi, Anna Grassi, Savina Ferorelli, Gennaro Cormio, Antonio Scilimati · 2019 · Current Medicinal Chemistry
50. Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
    Annacarmen Petrizzo, Concetta Ragone, Beatrice Cavalluzzo, Angela Mauriello, Carmen Manolio, Maria Tagliamonte, Luigi Buonaguro · 2021 · Cancers
51. Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
    Jessica M. Salmon, Izabela Todorovski, Kym L. Stanley, Claudia Bruedigam, Conor J. Kearney, Luciano Gastón Martelotto, Fernando Jaime Rossello, Timothy J. Semple, Gisela Mir Arnau, Magnus Zethoven et al. · 2022 · Cancer Discovery
52. Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
    Chen Jie, Rumeng Li, Yajie Cheng, Zhihao Wang, Qiuji Wu, Conghua Xie · 2023 · Frontiers in Immunology
53. DNA methyltransferase inhibitor exposure–response: Challenges and opportunities
    Amanda B. Kagan, Dominique A. Garrison, Nicole M. Anders, Jonathan Allen Webster, Sharyn D. Baker, Srinivasan Yegnasubramanian, Michelle A. Rudek · 2023 · Clinical and Translational Science
54. Retinoic acid signaling in development and differentiation commitment and its regulatory topology
    Di Wu, Faheem Ahmed Khan, Kejia Zhang, Nuruliarizki Shinta Pandupuspitasari, Windu Negara, Kaifeng Guan, Fei Sun, Chunjie Huang · 2023 · Chemico-Biological Interactions
55. Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors
    Reiner Strick, Pamela L. Strissel, Stephen B. Baylin, Katherine Bakshian Chiappinelli · 2015 · OncoImmunology
56. Senescence induction universally activates transposable element expression
    Anthony Colombo, Harold Kunal Elias, Giridharan Ramsingh · 2018 · Cell Cycle
57. Aging-associated patterns in the expression of human endogenous retroviruses
    Tapio Nevalainen, Arttu Autio, Binisha Hamal Mishra, Saara Marttila, Marja K. Jylhä, Mikko Hurme · 2018 · PLoS ONE
58. MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response
    Jeroen Witteveldt, Lisanne I Knol, Sara Macías · 2019 · eLife
59. Evidence of Aberrant Immune Response by Endogenous Double‐Stranded RNAs: Attack from Within
    Sujin Kim, Yongsuk Ku, Jayoung Ku, Yoosik Kim · 2019 · BioEssays
60. The use of DNA methylation clock in aging research
    Xi He, Jiaojiao Liu, Bo Liu, Jingshan Shi · 2020 · Experimental Biology and Medicine
61. Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition
    Raghav Sundar, Kie Kyon Huang, Vikrant Kumar, Kalpana Ramnarayanan, Deniz Demircioğlu, Zhisheng Her, Xuewen Ong, Zul Fazreen Bin Adam Isa, Manjie Xing, Angie Lay-Keng Tan et al. · 2021 · Gut
62. Hypomethylating agents for the treatment of myelodysplastic syndromes and acute myeloid leukemia: Past discoveries and future directions
    Nicholas James Short, Hagop M. Kantarjian · 2022 · American Journal of Hematology
63. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response
    Eric U. Russ, Natallia Mikhalkevich, Sergey Iordanskiy · 2023 · Microbiology Spectrum
64. uhrf1 and dnmt1 Loss Induces an Immune Response in Zebrafish Livers Due to Viral Mimicry by Transposable Elements
    Elena Magnani, Filippo Macchi, Bhavani P. Madakashira, Chi Zhang, Fatima AlAydaroos, Kirsten C. Sadler · 2021 · Frontiers in Immunology
65. Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
    Christina E. Sparbier, Andrea Gillespie, Juliana Gomez, Nishi Kumari, Ali Motazedian, Kah Lok Chan, Charles C. Bell, Omer Gilan, Yih-Chih Chan, Sarah Popp et al. · 2023 · Nature Cell Biology
66. MAGE-C2–Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses
    André Kunert, Mandy van Brakel, Sabine van Steenbergen‐Langeveld, Marvin da Silva, Pierre G. Coulie, Cor Lamers, Stefan Sleijfer, Reno Debets · 2016 · The Journal of Immunology
67. DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1/syncytin-1 in seminomas
    Martina Benešová, Kateřina Trejbalová, Denisa Kovářová, Zdeňka Vernerová, Tomáš Hron, Dana Kučerová, Jiřı́ Hejnar · 2017 · Retrovirology
68. The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
    Abdul S. Qadir, Austin M. Stults, Andrea E. Murmann, Marcus E. Peter · 2020 · Scientific Reports
69. All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells
    Marco Bolis, Gabriela Paroni, Maddalena Fratelli, Arianna Vallerga, Luca Guarrera, Adriana Zanetti, Mami Kurosaki, Silvio Ken Garattini, Maurizio Gianni’, Monica Lupi et al. · 2020 · Cancers
70. Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer
    Damien J. Zanker, Alex Spurling, Natasha K. Brockwell, Katie L. Owen, Jasmine M. Zakhour, Tina Robinson, Hendrika M. Duivenvoorden, Paul J. Hertzog, Stefanie Mullins, Robert W. Wilkinson et al. · 2020 · Clinical & Translational Immunology
71. Immune and inflammatory responses to DNA damage in cancer and aging
    Clara Soria‐Valles, Alejandro López‐Soto, Fernando G. Osorio, Carlos López-Otín · 2016 · Mechanisms of Ageing and Development
72. DUSP11-mediated control of 5′-triphosphate RNA regulates RIG-I sensitivity
    Joon H. Choi, James M. Burke, Kayla H. Szymanik, Upasana Nepal, Anna M. Battenhouse, Justin T. Lau, Aaron Stark, Victor L. Lam, Christopher S. Sullivan · 2020 · Genes & Development
73. Critically short telomeres derepress retrotransposons to promote genome instability in embryonic stem cells
    Nannan Zhao, Guoxing Yin, Chun Liu, Weiyu Zhang, Yang Shen, Dan Wang, Zhenzhen Lin, Jiao Yang, Jian Mao, Renpeng Guo et al. · 2023 · Cell Discovery
74. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma
    Michael F. Sharpnack, Bin Chen, Dvir Aran, Idit Kosti, Douglas D. Sharpnack, David Paul Carbone, Parag Mallick, Kun Huang · 2017 · EBioMedicine
75. HERV-W group evolutionary history in non-human primates: characterization of ERV-W orthologs in Catarrhini and related ERV groups in Platyrrhini
    Nicole Grandi, Marta Cadeddu, Jonas Blomberg, Jens M. Mayer, Enzo Tramontano · 2018 · BMC Evolutionary Biology
76. Intracellular RNA Sensing in Mammalian Cells: Role in Stress Response and Cancer Therapies
    Nikolai N. Khodarev · 2018 · International review of cytology
77. Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy
    Carolina Fazio, Alessia Covre, Ornella Cutaia, Maria Fortunata Lofiego, Patrizia Tunici, Carla Chiarucci, Sara Cannito, Gianluca Giacobini, James N. Lowder, Roberta Ferraldeschi et al. · 2018 · Frontiers in Pharmacology
78. Dissecting the Immune Landscape of Acute Myeloid Leukemia
    Jan Kenneth Davidson-Moncada, Elena Viboch, SE Church, Sarah E. Warren, Sergio Rutella · 2018 · Biomedicines
79. Transcriptome analyses of tumor-adjacent somatic tissues reveal genes co-expressed with transposable elements
    Nicky Chung, G. M. Jonaid, Sophia Quinton, Austin Ross, Corinne E. Sexton, Adrian Alberto, Cody Clymer, Daphnie Churchill, Omar Navarro Leija, Mira Han · 2019 · Mobile DNA
80. Awakening the dark side: retrotransposon activation in neurodegenerative disorders
    Ochoa Thomas, Elizabeth, Zuniga, Gabbe, Sun, Wenyan, Frost, Bess · 2020 · Current Opinion in Neurobiology
81. Epigenetic modulation of immunotherapy and implications in head and neck cancer
    Liye Zhou, Na Xu, Hirofumi Shibata, Vassiliki Saloura, Ravindra Uppaluri · 2021 · Cancer and Metastasis Reviews
82. Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
    Pere Llinàs‐Arias, Sandra Íñiguez-Muñoz, Kelly Elizabeth McCann, Leonie Voorwerk, Javier I. J. Orozco, Miquel Ensenyat-Méndez, Borja Sesé, Maggie Lee DiNome, Diego M. Marzese · 2021 · Cancers
83. Overexpression of transposable elements is associated with immune evasion and poor outcome in colorectal cancer
    Zhu, Xiaoqiang, Fang, Hu, Gladysz, Kornelia, Barbour, Jayne A., Wong, Jason W.H. · 2021 · European Journal of Cancer
84. Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks
    Jin Li, Yan Li, Wei Li, Huai-Bing Luo, Yan-Ping Xi, Shi-Hua Dong, Ming Gao, Peng Xu, Bao-Long Zhang, Ying Liang et al. · 2019 · Genome Research
85. Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors
    Jason J. Luke, Marwan Fakih, Charles John Schneider, Elena Gabriela Chiorean, Johanna C. Bendell, Rebecca Sophie Kristeleit, Razelle Kurzrock, Sarah Patricia Blagden, Irene Braña, Laura Williams Goff et al. · 2023 · British Journal of Cancer
86. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
    Kun Chan Zheng, Youlong Hai, Hongqi Chen, Yukun Zhang, Xiaoyong Hu, Kai Ni · 2024 · Journal of Translational Medicine
87. AZA-MS: a novel multiparameter mass spectrometry method to determine the intracellular dynamics of azacitidine therapy in vivo
    Ashwin Unnikrishnan, A N Q Vo, Russell Pickford, Mark J. Raftery, Andrea C. Nunez, Arjun Verma, Luke B. Hesson, John E. Pimanda · 2017 · Leukemia
88. CRlncRC: a machine learning-based method for cancer-related long noncoding RNA identification using integrated features
    Xuan Zhang, Jun Wang, Jing Li, Wen Chen, Changning Liu · 2018 · BMC Medical Genomics
89. Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer
    Victoria M. Kim, Xingyi Pan, Kevin C. Soares, Nilofer Saba Azad, Nita Ahuja, Christopher J. Gamper, Alex B. Blair, Stephen T. Muth, Ding Ding, Brian H. Ladle et al. · 2020 · JCI Insight
90. Monocyte-released HERV-K dUTPase engages TLR4 and MCAM causing endothelial mesenchymal transition
    Shoichiro Otsuki, Toshie Saito, Shalina Taylor, Dan Li, Jan-Renier A. J. Moonen, David P. Marciano, Rebecca L. Harper, Aiqin Cao, Lingli Wang, Maria Eugenia Ariza et al. · 2021 · JCI Insight
91. EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma
    Tianxiao Xu, Jie Dai, Lirui Tang, Lu Yang, Lu Si, Xinan Sheng, Chuanliang Cui, Zhihong Chi, Yan Kong, Jun Guo · 2021 · Journal of Investigative Dermatology
92. PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
    Amish J. Patel, Sarah Warda, Jesper L.V. Mååg, Rohan Misra, Miguel A. Miranda-Román, Mohini R. Pachai, Cindy J. Lee, Dan Li, Naitao Wang, Gabriella Bayshtok et al. · 2022 · Cancer Discovery
93. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
    Swathi Ramakrishnan, Qiang Hu, Nithya Krishnan, Dan Wang, Evelyn Smit, Victoria Granger, Monika Rak, Kristopher M. Attwood, Candace S. Johnson, Carl Morrison et al. · 2017 · Cell Death and Disease
94. Activation of Endogenous Retrovirus, Brain Infections and Environmental Insults in Neurodegeneration and Alzheimer’s Disease
    Licastro, Federico, Porcellini, Elisa · 2021 · International Journal of Molecular Sciences
95. Endogenous retroelements as alarms for disruptions to cellular homeostasis
    Håvard T. Lindholm, Raymond E. Chen, Daniel Diniz De Carvalho · 2022 · Trends in cancer
96. Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens
    Melissa M. Wolf, W. Kimryn Rathmell, Aguirre A. de Cubas · 2023 · Nature Reviews Nephrology
97. The RNA polymerase III–RIG-I axis in antiviral immunity and inflammation
    Leslie Naesens, Filomeen Haerynck, Michaela Ulrike Gack · 2023 · Trends in Immunology
98. Targeting the loss of cGAS / STING signaling in cancer
    Nobunari Sasaki, Mizuki Homme, Shunsuke Kitajima · 2023 · Cancer Science
99. Noncanonical MAVS signaling restrains dendritic cell–driven antitumor immunity by inhibiting IL-12
    Lingling Wu, Xiaochuan Hong, Chao Xian Yang, Yuanqin Yang, Wenwen Li, Lu Lu, Mei‐Chun Cai, Dongqing Cao, Guanglei Zhuang, Liufu Deng · 2023 · Science Immunology
100. DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I/MDA5-MAVS to enhance antitumor immunity
     Yao Tu, Qingyun Zhu, Wenjun Huang, Sha Feng, Ya Tan, Lulu Li, Xin-tong Xie, Qin-yuan Li, Shou-hui Huang, Chengzhou Mao et al. · 2025 · Acta Pharmacologica Sinica